3Liebman HA, Stasi R. Secondary immune thrombocytopenic purpura[J]. Curr Opin Hematol, 2007, 14(5): 557.
4Liebman HA. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders[J]. Semin in Hematol, 2009, 46: 33-36.
8CDC. Are there any side effects to the 2009 H1N1 influenza vaccine[E/OB]. 2009-12-15. http://www, cdc. gov/h1n1flu/ vaccination/vaccine_safety_qa, htm#b.
2[1]FurlanM,Robles R,Solenthaler M,et al.Acquireed deficiency of von willebrand factor-cleaving protease in a patient with thrombotic thrombocypenic pupura[J].Blood,1998,91:2839.
5[6]Bobbio Pallavicini E,Gugliotta L,Centurioni R,et al.Antiplatelet agents in thrombotic thrombocytopenic purpura(TTP).Result of a randomized multicenter trial by the Italian Cooperative Group forTTP[J].Haematologica,1997,82:429.
6[7]Gutterman LA.Thrombotic thrombocytopenic purpura:prospective treatment with a standandized regimen[J].Fransfus Sei,1992,13:45.
